Statin use does not decrease the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis

Expert Rev Gastroenterol Hepatol. 2020 Jul;14(7):511-513. doi: 10.1080/17474124.2020.1770595. Epub 2020 May 28.

Authors

Antonio Facciorusso¹, Vincenzo Rosario Buccino¹, Paolo Tonti¹, Rodolfo Sacco¹

Affiliation

¹ Gastroenterology Unit, Department of Medical Sciences, University of Foggia , Foggia, Italy.

PMID: 32462964
DOI: 10.1080/17474124.2020.1770595

No abstract available

Keywords: Biliary; ERCP; inflammation; pancreas; statin.

Publication types

Editorial

MeSH terms

Aged
Aged, 80 and over
Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Incidence
Male
Middle Aged
Pancreatitis / epidemiology*
Pancreatitis / prevention & control*
Retrospective Studies

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors